U.S. IPO Week Ahead: Healthcare And Micro-Caps Dominate Week With Up To 8 IPOs

U.S. IPO Week Ahead: Just 2 Micro-Cap IPOs Expected In Short Week With 6+ Potential Launches.....»»

There are 10 160 IPOs expected to price this week 160 after the July holiday slowdown The week is being led by oil and gas OEM AFG Holdings and Canadian cannabis supplier Tilray Six healthcare companies are also pricing this week with two 100 mm deals.....»»

Biotech stocks reversed course in the week ended April 16, with the sector re.....»»

Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vaccine updates, M&A activity, IPO news flow and follow-on offerings all served to lift stocks higher. read more.....»»

Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vac.....»»

JPMorgan Chase & Co. CEO Jamie Dimon is to be among the keynote speakers at next week's J.P. Morgan Healthcare Conference. read more.....»»

Biotech stocks advanced for a third straight week, defying the broader market weakness. The space got solid support from positive stock reactions to presentations made at hematology and breast cancer conferences. read more.....»»

After logging its best week since the Ford administration, the mar.....»»

WeDoctor will push ahead with a Hong Kong listing and invite pitches from investments banks next week to lead an IPO valuing the Chinese healthcare platform at up to $10 billion, two sources with direct knowledge of the matter said......»»

Biotech news flow remained light last week, although there were some notable developments such as FDA panel reviews of opioid pain drugs, a few clinical data readouts, presentations and updates at the JPMorgan Healthcare conference. Here are the key c.....»»

Activity in the biotech space is likely to pick up this week. Events are likely to be headlined by the annual JPMorgan Healthcare Conference. 0 read more.....»»

Notwithstanding the ESMO conference generating some huge moves in some stocks, last week turned out to be a muted one for biotechs. read more.....»»

Biotech stocks came under selling pressure in the week ended Sept. 27 amid clinical data readouts and a handful of FDA decisions. read more.....»»

Overbought markets "tend to get hit with sell-offs, especially when we're being flooded with shoddy IPOs," Jim Cramer says......»»

Biotech stocks rebounded in last week after declining modestly in the previous week. read more.....»»

U.S. IPO Week Ahead: Summer"s Last Wave With 5 IPOs.....»»

Biotech stocks moved mostly sideways during the week, although there was .....»»

Biotech stocks moved mostly sideways during the week, although there was a flurry of activity in the space. Earnings from the sector began to trickle in, with Bristol-Myers Squibb Co (NYSE: BMY) reporting forecast-beating earnings. read more.....»»

Tenet Healthcare Corp (NYSE: THC) shares are up 19.2% in the past week after the company announced it's spinning off its payment processor Conifer after failing to find a buyer. read more.....»»

U.S. IPO Week Ahead: A Flurry Of IPOs Expected To Launch July Roadshows.....»»